Monday, August 13, 2018 6:57:17 PM
That puts CVSI above $6B in MC. I believe is too soon for that.
I will tel you a different and very possible story:
Uplisting SP between $6.50 & $7.5 (To be conservative).
The SP flying to $10.50- $12.00 right away (2 weeks min)
CVSI Offering 10M shares @ those prices. Why NOT? That's $100M+ IN CASH.
The company was operating with less than a $1M in cash a year and half ago and look what they have accomplished. Imagine NOW what they can do with a $100M and all the rules of the game written by them and their people in Washington.
First movers with a 2-3 years lead and another 2 years advantage once the Farm Bill is signed into law.
Wise money will stay to see all this happen. people are starting to give CVSI the respect the stock deserves and holding to their stock. And that's why the price will surge in the coming months..
So buckle up because this could end up being one of the best rides of your life.
I will tel you a different and very possible story:
Uplisting SP between $6.50 & $7.5 (To be conservative).
The SP flying to $10.50- $12.00 right away (2 weeks min)
CVSI Offering 10M shares @ those prices. Why NOT? That's $100M+ IN CASH.
The company was operating with less than a $1M in cash a year and half ago and look what they have accomplished. Imagine NOW what they can do with a $100M and all the rules of the game written by them and their people in Washington.
First movers with a 2-3 years lead and another 2 years advantage once the Farm Bill is signed into law.
Wise money will stay to see all this happen. people are starting to give CVSI the respect the stock deserves and holding to their stock. And that's why the price will surge in the coming months..
So buckle up because this could end up being one of the best rides of your life.
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2025 09:25:41 PM
